Home|Journals|Articles by Year|Audio Abstracts
 

Case Report



Topical Silver Sulfadiazine Trigger Hemolysis in a Child with Burn and Glucose 6 Phosphate Dehydrogenase Deficiency

Muneer Hassan Albagshi, Jaber A Alhabeeb, Randa Adel Hussein, Hakeema Alkamis, Murtadha Albagshi.




Abstract
Cited by 0 Articles

Glucose 6 phosphate dehydrogenase deficiency (G6PD deficiency) is the commonest red blood cell enzyme disorder that affects hundreds of millions around the globe. The red cells deficient in the enzyme become vulnerable to oxidative stress after exposure to certain drugs, chemicals, or food leading to hemolysis. We present a five-year-old boy admitted to burn unit after scold burn by boiling water. He was treated with an application of silver sulfadiazine cream to the burn sites, paracetamol, and intravenous fluids. The boy developed pallor and jaundice on the fifth day of admission with evidence of acute hemolysis and documented G6PD deficiency during the incidence. We hypothesize that sliver sulfadiazine could be absorbed through burn and trigger hemolysis in G6PD deficient individuals; therefore, replacing this antibiotic with a safe one is advised in these individuals, as well as introducing neonatal screening for G6PD deficiency in the high prevalent communities to avoid oxidative triggers and increase awareness in both health care workers as well as the general population.

Key words: Acute hemolysis, G6PD deficiency, Burn






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.